Kubota Vision Demonstrates 3D Imaging Capabilities Using AI on PBOS
SEATTLE--(BUSINESS WIRE)--Kubota Vision Inc. (“Kubota Vision”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), today announced that the company demonstrated 3D imaging capabilities using artificial intelligence (AI) on our Patient Based Ophthalmology Suite (PBOS), in-home optical coherence tomography (OCT) device.*1 Kubota Vision completed a successful clinical study in October 2018 that demonstrated the PBOS could de